omniture
logo
Search
德睿智药科技有限公司
Media Room

Latest News

rss

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial i...

2023-06-14 20:00 2504

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial i...

2023-06-14 20:00 1906

MindRank Announces U.S. FDA Clearance of IND Application for MDR-001, a Novel GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes and Obesity

SHANGHAI and HANGZHOU, China, Dec. 26, 2022 /PRNewswire/ -- MindRank, an artificial intelligence (...

2022-12-26 23:00 2496

MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation

HANGZHOU, China, Jan. 18, 2022 /PRNewswire/ -- MindRank AI, an artificial intelligence (AI) driven ...

2022-01-18 17:17 1162